271 related articles for article (PubMed ID: 19726209)
1. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
[TBL] [Abstract][Full Text] [Related]
3. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
Allen GP; Breathnach CC
Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
[TBL] [Abstract][Full Text] [Related]
4. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
[TBL] [Abstract][Full Text] [Related]
6. Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France.
Pronost S; Léon A; Legrand L; Fortier C; Miszczak F; Freymuth F; Fortier G
Vet Microbiol; 2010 Oct; 145(3-4):329-33. PubMed ID: 20427133
[TBL] [Abstract][Full Text] [Related]
7. Equid herpesvirus type-1 exhibits neurotropism and neurovirulence in a mouse model.
Mori CM; Mori E; Favaro LL; Santos CR; Lara MC; Villalobos EM; Cunha EM; Brandao PE; Richtzenhain LJ; Maiorka PC
J Comp Pathol; 2012; 146(2-3):202-10. PubMed ID: 21689826
[TBL] [Abstract][Full Text] [Related]
8. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
Dunowska M
N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
[TBL] [Abstract][Full Text] [Related]
9. Coagulation parameters following equine herpesvirus type 1 infection in horses.
Wilson ME; Holz CL; Kopec AK; Dau JJ; Luyendyk JP; Soboll Hussey G
Equine Vet J; 2019 Jan; 51(1):102-107. PubMed ID: 29658149
[TBL] [Abstract][Full Text] [Related]
10. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California.
Pusterla N; Wilson WD; Mapes S; Finno C; Isbell D; Arthur RM; Ferraro GL
Vet J; 2009 Feb; 179(2):230-9. PubMed ID: 18024200
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak.
Traub-Dargatz JL; Pelzel-McCluskey AM; Creekmore LH; Geiser-Novotny S; Kasari TR; Wiedenheft AM; Bush EJ; Bjork KE
J Vet Intern Med; 2013; 27(2):339-46. PubMed ID: 23398291
[TBL] [Abstract][Full Text] [Related]
12. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.
Pusterla N; David Wilson W; Madigan JE; Ferraro GL
Vet J; 2009 Jun; 180(3):279-89. PubMed ID: 18805030
[TBL] [Abstract][Full Text] [Related]
13. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
[TBL] [Abstract][Full Text] [Related]
14. Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions.
Hussey GS; Goehring LS; Lunn DP; Hussey SB; Huang T; Osterrieder N; Powell C; Hand J; Holz C; Slater J
Vet Res; 2013 Dec; 44(1):118. PubMed ID: 24308772
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of equine herpesvirus myeloencephalopathy in France: a clinical and molecular investigation.
Pronost S; Legrand L; Pitel PH; Wegge B; Lissens J; Freymuth F; Richard E; Fortier G
Transbound Emerg Dis; 2012 Jun; 59(3):256-63. PubMed ID: 21975071
[TBL] [Abstract][Full Text] [Related]
16. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
17. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
[TBL] [Abstract][Full Text] [Related]
18. Neuropathogenic and non-neuropathogenic genotypes of Equid Herpesvirus type 1 in Argentina.
Vissani MA; Becerra ML; Olguín Perglione C; Tordoya MS; Miño S; Barrandeguy M
Vet Microbiol; 2009 Nov; 139(3-4):361-4. PubMed ID: 19589651
[TBL] [Abstract][Full Text] [Related]
19. Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses.
Allen GP
Am J Vet Res; 2006 Aug; 67(8):1401-5. PubMed ID: 16881853
[TBL] [Abstract][Full Text] [Related]
20. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
Dunowska M
N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
